Artificial intelligence (AI) may have the capacity to extend its reach into virtually every industry and profession, and pharmacy is no exception. While professionals in many industries may envision ways in which the technology could make their jobs obsolete, there might be more reason for excitement than dread about the potential role for AI in pharmacy practice.

Sonya Collins

Recently, an error occurred at a health system specialty pharmacy that delivers prescriptions to onsite clinics when patients come in to meet with providers.

Institute for Safe Medication Practices, Horsham, PA

Judicial rulings in the large volume of opioid-related lawsuits continue to clarify pharmacists’ legal responsibilities that are broadly applicable beyond opioid litigation. A recent case from New Jersey addresses a novel approach to pharmacist liability.

David B. Brushwood, BSPharm, JD

Across the country, patients are finding it increasingly difficult to access the services of a primary care physician (PCP)—a situation that likely will not improve anytime soon.

Elizabeth Briand

In late 2023, DEA announced that it will continue to allow health care providers to use telemedicine to prescribe certain controlled substances through the end of 2024.

Loren Bonner

Research published in JAMA demonstrates the value that a pharmacist-led intervention provides to Hispanic patients with T2D.

Jonathan Little, PharmD

At the end of September, over 30 CVS pharmacists in the Kansas City metro area walked off the job. Their reason? Working conditions that put patients at risk.

Loren Bonner

Updates from FDA

When discussing cholesterol, most clinicians cite HDL and LDL as the primary cholesterol factors influencing atherosclerotic risk. Lipoprotein(a), also known as Lp(a), is another, less commonly discussed piece of the puzzle in determining risk for atherosclerotic CVD (ASCVD).

Olivia C. Welter, PharmD

In July of 2023, the American Association for Clinical Chemistry and American Diabetes Association issued an update to the Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus, which were originally published in 2002.

Lauren Howell, PharmD

In September 2023, FDA approved Exxua (gepirone), a new extendedrelease antidepressant. When Exxua comes to the market in early 2024, it will mark a new treatment option for the estimated 21 million Americans who are affected by major depressive disorder (MDD) each year.

Lauren Howell, PharmD

DHEA supplements are advertised as an antidote to aging. Products on store shelves also purport that DHEA supports immune balance, metabolism, sexual health, mood, and bone and cardiovascular health. What is DHEA and what does it really do?

Mickie Cathers

Colds and flu often result in chest congestion that can persist long after other symptoms have disappeared. An expectorant like guaifenesin can help thin mucus and phlegm and make it easier to cough up.

Mary Warner

A randomized crossover trial published in the October 2023 issue of JAMA Internal Medicine demonstrated that inappropriately sized BP cuffs significantly affected BP measurement accuracy.

Clarissa Chan, PharmD

Trending Topics

An estimated 1.6 million to 3.8 million nursing home residents acquire a health care–associated infection each year. It’s one of the most common reasons for hospitalization and even death in this patient population.

Loren Bonner

In the dynamic landscape of HIV prevention and treatment, the U.S. Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV are at the forefront.

Corey Diamond, PharmD

For clinicians who work in acute care settings, some practical guidance pertaining to drug–drug interactions (DDIs) for the treatment of patients with COVID-19 is finally available.

Loren Bonner

The legislative, regulatory, societal, and economic issues impacting the pharmacy community in 2023 resulted in some wins, some losses, and some continuing challenges that will carry into 2024.

APhA Member News

Crossword Challenge